C/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment

Blood

Volumn 110, Issue 9, 2007, Pages 3136-3142

  Yeamans, Christine ^a   Wang, Dehua ^a   Paz Priel, Ido ^a   Torbett, Bruce E ^b   Tenen, Daniel G ^c   Friedman, Alan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSCRIPTION FACTOR PU 1; CCAAT ENHANCER BINDING PROTEIN ALPHA; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; BONE MARROW CULTURE; CELL LINEAGE; CELL MATURATION; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENHANCER REGION; GENE ACTIVATION; GENE INDUCTION; GENE MUTATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; STEM CELL; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN U937; CYTOLOGY; GENETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); HEMATOPOIESIS; HUMANS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MONOCYTES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; U937 CELLS;

EID: 35348815320     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-03-080291     Document Type: Article

References (44)

1. Friedman AD. Transcriptional regulation of granulocyte and monocyte development. Oncogene. 2002;21:3377-3390.
2. Scott LM, Civin CI, Rorth P, Friedman AD. A novel temporal pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood. 1992;80:1725-1735.
3. Klemsz MJ, McKercher SR, Celada A, Van Beveran C, Maki RA. The macrophage and B cell-specific transcription factor PU. 1 is related to the ets oncogene. Cell. 1990;61:113-124.
4. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of G-CSF signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc Natl Acad Sci U S A. 1997;94:569-574.
5. Zhang P, Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity. 2004;21:853-863.
6. Heath V, Suh HC, Holman M, et al. C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood. 2004;104:1639-1647.
7. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573-1577.
8. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU. 1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15:5647-5658.
9. Iwasaki H, Somoza C, Shigematsu H, et al. Distinctive and indispensable roles of PU. 1 in maintenance of hematopoietic stem cells and their differentiation. Blood. 2005;106:1590-1600.
10. DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU. 1. Science. 2000;288:1439-1441.
11. + embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells. Proc Natl Acad Sci U S A. 2005;102:13236-13241.
12. Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU. 1:C/EBPα ratio and granulocyte colony-stimulating factor. Nat Immunol. 2003;4:1029-1036.
13. Rosenbauer F, Wagner K, Kutok JL, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1. Nat Genet. 2004;36:624-630.
14. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU. 1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201:1487-1502.
15. Xie H, Graf T. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117:663-676.
16. Wang D, D'Costa J, Civin CI, Friedman AD. C/EBPα directs monocytic commitment of primary myeloid progenitors. Blood. 2006;108:1223-1229.
17. Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPα by-passes G-CSF signals to rapidly induce PU. 1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts. Blood. 1999;94:560-571.
18. Kummalue T, Friedman AD. Cross-talk between regulators of myeloid development: C/EBPα binds and activates the promoter of the PU. 1 gene. J Leuk Biol. 2003;72:464-470.
19. Okuno Y, Huang G, Rosenbauer F, et al. Potential autroregulation of transcription factor PU. 1 by an upstream regulatory element. Mol Cell Biol. 2005;25:2832-2845.
20. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinsi JF. Phorbol esterinduced myeloid differentiation is mediated by protein kinase C-α and -δ and not by protein kinase C-β II, ε, ζ, and η. J Biol Chem. 1993;268:20110-20115.
21. Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced Meis expression. Mol Cell Biol. 2000;98:2382-2388.
22. Anderson KL, Smith KA, Perkin H, et al. PU. 1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood. 1999;94:2310-2318.
23. Suzow JG, Friedman AD. The murine myeloperoxidase promoter contains multiple functional elements: one element binds a cell type-restricted transcription factor, myeloid nuclear factor 1(MyNF1). Mol Cell Biol. 1993;13:2141-2151.
24. Finer MH, Dull TJ, Qin L, Farson D, Roberts MR. Kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood. 1994;83:43-50.
25. Rosenbauer F, Owens BM, Yu L, et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat Genet. 2006;38:27-37.
26. Porse BT, Pedersen TA, Xu X, et al. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell. 2001;107:247-258.
27. Wang Q, Cleaves R, Kummalue T, Nerlov C, Friedman AD. Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis. Oncogene. 2003;22:2548-2557.
28. Pevny L, Simon MC, Robertson E, et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;34:257-260.
29. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16:3965-3973.
30. Chen H, Ray-Gallet D, Zhang P, et al. PU. 1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene. 1995;11:1549-1560.
31. Tsai SF, Strauss E, Orkin SH. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev. 1991;5:919-931.
32. Christy RJ, Kaestner KH, Geiman DE, Lane MD. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A. 1991;88:2593-2597.
33. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU. 1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13:1398-1411.
34. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU. 1. Proc Natl Acad Sci U S A. 1999;96:8705-8710.
35. Zhang P, Zhang X, Iwama A, et al. PU. 1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood. 2000;96:2641-2648.
36. Hsu CL, King-Fleischman AG, Lai AY, Matsumoto Y, Weissman IL, Kondo M. Antagonstic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc Natl Acad Sci U S A. 2006;103:672-677.
37. Huang G, Zhang P, Hirai H, et al. PU. 1 is a major downstream target of AML1/RUNX1 in adult hematopoiesis. Nature Genet. 2007; in press.
38. Mueller BU, Pabst T, Osato M, et al. Heterozygous PU. 1 mutations are associated with acute myeloid leukemia. Blood. 2002;100:998-1007.
39. Pabst T, Mueller BU, Zhang P, et al. Dominantnegative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat Genet. 2001;27:263-270.
40. Pabst T, Mueller BU, Harakawa N, et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia. Nat Med. 2001;7:444-451.
41. Zheng R, Friedman AD, Small D. Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations. Blood. 2002;100:4154-4161.
42. Perrotti D, Cesi V, Trotta R, et al. BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2. Nat Genet. 2002;30:48-58.
43. Radomska HS, Basseres DS, Zheng R, et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med. 2006;203:371-381.
44. Mueller BU, Pabst T, Fos J, et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU. 1 expression. Blood. 2006;107:3330-3338.